Onward Medical N.V./€ONWD
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Onward Medical N.V.
Onward Medical N.V. is a medical technology company specializing in developing therapies aimed at restoring movement and function in individuals with spinal cord injuries and other movement disabilities. Founded in 2014 by neuroscience researchers at the Swiss Federal Institute of Technology (EPFL), the company is headquartered in Eindhoven, the Netherlands, with additional offices in Lausanne, Switzerland, and Boston, Massachusetts. Its primary products include the ARC-EX, a non-invasive system designed to improve upper extremity strength and function, and the ARC-IM, an implantable system targeting blood pressure instability and other symptoms associated with spinal cord injuries. Onward Medical's strategic positioning is reinforced by its focus on neurostimulation technologies and brain-computer interfaces, as evidenced by recent advancements in these areas.
Ticker
€ONWD
Sector
Primary listing
BSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
103
ISIN
NL0015000HT4
Website
ONWD Metrics
BasicAdvanced
€200M
-
-€0.80
0.85
-
Price and volume
Market cap
€200M
Beta
0.85
52-week high
€7.24
52-week low
€3.50
Average daily volume
81K
Financial strength
Current ratio
6.847
Quick ratio
6.574
Long term debt to equity
30.154
Total debt to equity
31.396
Interest coverage (TTM)
-38.78%
Profitability
EBITDA (TTM)
-34.506
Gross margin (TTM)
-2,052.94%
Net profit margin (TTM)
-2,100.00%
Operating margin (TTM)
-2,052.94%
Effective tax rate (TTM)
0.11%
Revenue per employee (TTM)
€20,000
Management effectiveness
Return on assets (TTM)
-36.37%
Return on equity (TTM)
-108.28%
Valuation
Price to revenue (TTM)
115.437
Price to book
4.17
Price to tangible book (TTM)
5.33
Price to free cash flow (TTM)
-6.29
Free cash flow yield (TTM)
-15.90%
Free cash flow per share (TTM)
-71.51%
Growth
Revenue change (TTM)
226.88%
Earnings per share change (TTM)
-33.29%
3-year revenue growth (CAGR)
7.52%
3-year earnings per share growth (CAGR)
-39.53%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Onward Medical N.V. stock?
Onward Medical N.V. (ONWD) has a market cap of €200M as of July 02, 2025.
What is the P/E ratio for Onward Medical N.V. stock?
The price to earnings (P/E) ratio for Onward Medical N.V. (ONWD) stock is 0 as of July 02, 2025.
Does Onward Medical N.V. stock pay dividends?
No, Onward Medical N.V. (ONWD) stock does not pay dividends to its shareholders as of July 02, 2025.
When is the next Onward Medical N.V. dividend payment date?
Onward Medical N.V. (ONWD) stock does not pay dividends to its shareholders.
What is the beta indicator for Onward Medical N.V.?
Onward Medical N.V. (ONWD) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.